PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: B3C Communications

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

B3C Newswire Named Official Newswire Partner of BIOTECHNICA 2010 for the International Trade Media - b3c newswire, the first PR distribution service completely dedicated to biotech, announces that BIOTECHNICA 2010 has chosen b3c newswire to be the official newswire partner for the international biotech and pharmaceutical trade media
B3C Newswire Named Official Newswire Partner of BIOTECHNICA 2010 for the International Trade Media

 

NewswireToday - /newswire/ - Traunstein, Germany, 2010/05/04 - b3c newswire, the first PR distribution service completely dedicated to biotech, announces that BIOTECHNICA 2010 has chosen b3c newswire to be the official newswire partner for the international biotech and pharmaceutical trade media.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

“The reach in trade media and the quality of our hand-picked media titles are unrivaled. b3c newswire offers many specialized channels, a targeted biotech Twitter network and access to thousands of biotech professionals through social media to assure excellent visibility and awareness of news releases,” says Dr. Sabine Duntze from b3c newswire. “We are delighted to be the official newswire partner for BIOTECHNICA 2010 for the trade media worldwide.”

Main features of b3c newswire:

• Largest reach in biotech and pharmaceutical trade media worldwide;
• Many specialized channels;
• News is distributed according to the editors’ preferences for maximum awareness;
• News is indexed in Google News and Yahoo!;
• Access to a targeted biotech Twitter network;
• Reaches thousands of biotech professionals through social media.

About b3c newswire

b3c newswire (b3cnewswire.com) is the first PR distribution service completely dedicated to biotech. b3c newswire media network stands out for its quality and reach targeting print, online and social media for subjects related to biotechnology, pharmaceuticals, life sciences, or health care. In addition, b3c serves a targeted Twitter network for maximum visibility. Founded by a team of experienced biotech PR consultants with a life sciences background, b3c newswire combines PR and life science expertise.

About Biotechnica

BIOTECHNICA (biotechnica.de) is Europe’s leading annual event for biotechnology and the life sciences. It covers the entire spectrum of biotechnology, including fundamentals and equipment, bio-informatics and services, and addresses all five major fields of application, i.e. pharma-ceuticals/medicine, industrial manufacturing, food, agriculture and the environment. Ever since 1985, BIOTECHNICA has been organized and staged by Deutsche Messe AG in Hannover, Germany.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: B3C Communications

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


B3C Newswire Named Official Newswire Partner of BIOTECHNICA 2010 for the International Trade Media

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Sabine Duntze - B3C.de 
+49 8619098220 info[.]b3cnewswire.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any B3C Communications securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From B3C Communications / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)